This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:SubstanceBox/Loperamide: Difference between revisions
Jump to navigation
Jump to search
>Tracer m Changed ChemicalClass |
>Uwabaki updated max total duration based on personal experience |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 52: | Line 52: | ||
|OralROA_Collapsed=false | |OralROA_Collapsed=false | ||
|OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> | |OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability=0.3%<ref>https://www.medicines.org.uk/emc/product/770/smpc</ref> | ||
|OralROA_Threshold=[[Oral threshold dose::16]] - [[Oral dose units::30]] mg | |OralROA_Threshold=[[Oral threshold dose::16]] - [[Oral dose units::30]] mg | ||
|OralROA_Light=[[Oral min light dose::30]] - [[Oral max light dose::50]] mg | |OralROA_Light=[[Oral min light dose::30]] - [[Oral max light dose::50]] mg | ||
| Line 60: | Line 60: | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration=[[Oral min total time::24]] - [[Oral max total time:: | |OralROA_Duration=[[Oral min total time::24]] - [[Oral max total time::48]] [[Oral total time units::hours]] | ||
|OralROA_Onset= | |OralROA_Onset= 1 - 4 hours | ||
|OralROA_Peak= | |OralROA_Peak= 6 - 16 hours | ||
|OralROA_Offset= | |OralROA_Offset= 4 - 8 hours | ||
|OralROA_Aftereffects= | |OralROA_Aftereffects= | ||
}} | }} | ||
Latest revision as of 14:18, 6 May 2022
| SubstanceBox/Loperamide | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||||||
| Common names | Loperamide, Imodium, Entrocalm | ||||||||||||||||||||||||||||||
| Substitutive name | Loperamide | ||||||||||||||||||||||||||||||
| Systematic name | 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide | ||||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||||
| Psychoactive class | Opioid | ||||||||||||||||||||||||||||||
| Chemical class | Phenylpiperidine / Diphenylpropylamine | ||||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||